UA99112C2 - Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile - Google Patents

Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile

Info

Publication number
UA99112C2
UA99112C2 UAA200903416A UAA200903416A UA99112C2 UA 99112 C2 UA99112 C2 UA 99112C2 UA A200903416 A UAA200903416 A UA A200903416A UA A200903416 A UAA200903416 A UA A200903416A UA 99112 C2 UA99112 C2 UA 99112C2
Authority
UA
Ukraine
Prior art keywords
fluorobenzonitrile
dioxo
pyrimidin
piperidin
ylmethyl
Prior art date
Application number
UAA200903416A
Other languages
English (en)
Ukrainian (uk)
Inventor
Роналд Дж. Кристофер
Ацуси Огава
Пол Ковингтон
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/035958 external-priority patent/WO2007033350A1/en
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of UA99112C2 publication Critical patent/UA99112C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к области медицины и касается применения 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2Н-пиримидин-1-илметил]-4-фторбензонитрила (соединение I) или его фармацевтически приемлемой соли для лечения заболевания или состояния, для которого показано ингибирование DPP-IV, в частности для лечения диабета, путем введения пациенту еженедельной дозы от 50 до 250 мг соединения I один раз в неделю.
UAA200903416A 2006-09-13 2007-09-11 Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile UA99112C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/035958 WO2007033350A1 (en) 2005-09-14 2006-09-13 Dipeptidyl peptidase inhibitors for treating diabetes

Publications (1)

Publication Number Publication Date
UA99112C2 true UA99112C2 (en) 2012-07-25

Family

ID=50851938

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200903416A UA99112C2 (en) 2006-09-13 2007-09-11 Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile

Country Status (1)

Country Link
UA (1) UA99112C2 (ru)

Similar Documents

Publication Publication Date Title
MY145447A (en) Use of 2-6(3-amino-piperidin-1-yl)-3-methyl-2, 4-dioxo-3, 4-dihydrp-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile
TW200744602A (en) Administration of dipeptidyl peptidase inhibitors
MY149157A (en) Weekly administration of dipeptidyl peptidase inhibitors
MY159522A (en) Administration of dipeptidyl peptidase inhibitors
MX2010004576A (es) Derivados de pirimidina novedosos.
IL199151A (en) Pyrimidine derivatives, their pharmaceutical preparations, their use in cancer treatment and their kits
IL192948A0 (en) Novel pyridine derivatives
IL192763A (en) History of pyrimidine, preparations containing them and used in the preparation of cancer drugs
CL2012000163A1 (es) Compuestos derivados de quinazolina o pirido[2,3-d]pirimidina, inhibidores de la autofagia; composicion farmaceutica; y su uso para el tratamiento del cancer, pancreatitis, neurodegeneracion, entre otras.
WO2007089768A3 (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
WO2009027644A8 (en) Compositions for the treatment of neoplastic diseases
WO2009108383A3 (en) Substituted xanthine derivatives
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2008027600A3 (en) Imatinib compositions
TW200738723A (en) 1-(1-(2-Ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and salts thereof
WO2007043094A3 (en) 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
UA99112C2 (en) Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
JO3254B1 (ar) مثبطات ببتيداز ثنائي ببتيديل لمعالجة مرض السكر
UA91717C2 (en) Administration of 2-[[6-[(3r)-3-amino-l-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo- l(2h)-pyrimaidinyl]methyl]-benzonitrile for the treatment of conditions mediated with dipeptidyl peptidase inhibitors
WO2010077734A3 (en) Novel antiviral compounds, compositions, and methods of use
CL2008001974A1 (es) Compuestos derivados de ciclopenta[d]pirimidina inhibidores de la quinasa akt; proceso de preparacion; kit farmaceutico; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, hiperproliferativas, cardiovasculares, neurode genarativas, entre otras.